BIT
KBIO

BlackRock Institutional Trust’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

BlackRock Institutional Trust’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40,000
Closed -$620K – 4061
2015
Q4 		$620K Hold
40,000
– – ﹤0.01% 3456
2015
Q3 		$76K Buy
+40,000
New +$105K ﹤0.01% 3768
2014
Q4 		– Sell
-6,316
Closed -$78K – 4003
2014
Q3 		$78K Hold
6,316
– – ﹤0.01% 3691
2014
Q2 		$115K Sell
6,316
-17,910
-74% -$307K ﹤0.01% 3752
2014
Q1 		$525K Sell
24,226
-22,099
-48% -$640K ﹤0.01% 3563
2013
Q4 		$1.64M Sell
46,325
-8,902
-16% -$298K ﹤0.01% 3238
2013
Q3 		$2M Sell
55,227
-3,736
-6% -$170K ﹤0.01% 3128
2013
Q2 		$2.67M Buy
+58,963
New +$2.67M ﹤0.01% 2953

Other funds holding KBIO

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Institutional Trust's KBIO Position: Q1 2016 in Review

BlackRock Institutional Trust sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 40,000 shares — an estimated $620K sold.

BlackRock Institutional Trust first reported a position in KBIO in Q2 2013 and held it in 8 quarters. The position peaked at $2.67M in Q2 2013. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

  • BlackRock Institutional Trust reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 40,000 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $620K.
  • BlackRock Institutional Trust first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock Institutional Trust's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $2.67M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on BlackRock Institutional Trust's 13F filing for Q1 2016, filed 10 May 2016.